ESPRIT IL-2: Evaluation of Subcutaneous Proleukin in a Randomized International Trial
Description
pulled from site's meta descriptionESPRIT is a randomized, international, 5-year, 4000-person study of interleukin-2 (IL-2) in people with HIV infection and a CD4+ (also called T4) cell count of at least 300/mm3. The goal of study is to evaluate and compare the effectiveness of IL-2 plus anti-HIV therapy versus anti-HIV therapy alone on numbers and severity of AIDS-related illnesses and deaths over a 5-year period.
Domain Resolution
This domain resolves to the following IP addresses:This is an automatically generated AboutUs page for espritstudy.org. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
